Search alternatives:
"epidemics" » "epidemic" (Expand Search)
Showing 1 - 19 results of 19 for search '"epidemics"', query time: 0.02s Refine Results
  1. 1
    القواعد والضوابط الفقهية المتعلقة بالأمراض والأوبئة وتطبيقاتها الفقهية :فيروس كوفيد 19-أنموذجًا

    القواعد والضوابط الفقهية المتعلقة بالأمراض والأوبئة وتطبيقاتها الفقهية :فيروس كوفيد 19-أنموذجًا by Nasr, Desouky Youssef Desouky

    Published 2023
    Subjects: Get full text
    article
    Save to List
    Saved in:
  2. 2
    دور مجلس الأمن في مواجهة الأوبئة: دراسة تحليلية على ضوء أزمه فيروس كورونا المستجد

    دور مجلس الأمن في مواجهة الأوبئة: دراسة تحليلية على ضوء أزمه فيروس كورونا المستجد by Emar , Omar Mahmoud

    Published 2021
    Subjects: Get full text
    article
    Save to List
    Saved in:
  3. 3
    Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors.

    Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.

    Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022.

    Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022.

    DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Univariate analysis between DENV and CHIKV seropositivity and selected risk factors.

    Univariate analysis between DENV and CHIKV seropositivity and selected risk factors. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.

    Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022.

    Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022..

    Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022.. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors.

    Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Univariate analysis between DENV and CHIKV seroconversion and selected risk factors.

    Univariate analysis between DENV and CHIKV seroconversion and selected risk factors. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Distribution of DENV and CHIKV seroprevalence by age group of participants in the study.

    Distribution of DENV and CHIKV seroprevalence by age group of participants in the study. by Bethel Alebel Bayrau (22676588)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Characteristics of participants.

    Characteristics of participants. by Karen Klein (6650600)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Database and Dictionary.

    Database and Dictionary. by Karen Klein (6650600)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Anticipated barriers to MNH-EPI-COS adoption in observational research studies and surveillance in the context of epidemics.

    Anticipated barriers to MNH-EPI-COS adoption in observational research studies and surveillance in the context of epidemics. by Karen Klein (6650600)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Acceptability for the inclusion of outcomes and definitions and feasibility of data collection for each outcome.

    Acceptability for the inclusion of outcomes and definitions and feasibility of data collection for each outcome. by Karen Klein (6650600)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    pgph.0005474.t005 -

    pgph.0005474.t005 - by Karen Klein (6650600)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Overall acceptability of the MNH-EPI-COS.

    Overall acceptability of the MNH-EPI-COS. by Karen Klein (6650600)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: